Lack of evidence for direct ligand-gated ion channel activity of GluD receptors.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
30 Jul 2024
Historique:
medline: 26 7 2024
pubmed: 26 7 2024
entrez: 25 7 2024
Statut: ppublish

Résumé

Delta receptors (GluD1 and GluD2), members of the large ionotropic glutamate receptor (iGluR) family, play a central role in numerous neurodevelopmental and psychiatric disorders. The amino-terminal domain (ATD) of GluD orchestrates synapse formation and maturation processes through its interaction with the Cbln family of synaptic organizers and neurexin (Nrxn). The transsynaptic triad of Nrxn-Cbln-GluD also serves as a potent regulator of synaptic plasticity, at both excitatory and inhibitory synapses. Despite these recognized functions, there is still debate as to whether GluD functions as a "canonical" ion channel, similar to other iGluRs. A recent report proposes that the ATD of GluD2 imposes conformational constraints on channel activity; removal of this constraint by binding to Cbln1 and Nrxn, or removal of the ATD, reveals channel activity in GluD2 upon administration of glycine (Gly) and d-serine (d-Ser), two GluD ligands. We were able to reproduce currents when Gly or d-Ser was administered to clusters of heterologous human embryonic kidney 293 (HEK293) cells expressing Cbln1, GluD2 (or GluD1), and Nrxn. However, Gly or d-Ser, but also l-glutamate (l-Glu), evoked similar currents in naive (i.e., untransfected) HEK293 cells and in GluD2-null Purkinje neurons. Furthermore, no current was detected in isolated HEK293 cells expressing GluD2 lacking the ATD upon administration of Gly. Taken together, these results cast doubt on the previously proposed hypothesis that extracellular ligands directly gate wild-type GluD channels.

Identifiants

pubmed: 39052831
doi: 10.1073/pnas.2406655121
doi:

Substances chimiques

glutamate receptor delta 1 0
glutamate receptor delta 2 0
Glycine TE7660XO1C
Ligand-Gated Ion Channels 0
Ligands 0
Receptors, Glutamate 0
Serine 452VLY9402

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2406655121

Subventions

Organisme : MEXT | Japan Society for the Promotion of Science (JSPS)
ID : 20H05628
Organisme : MEXT | Japan Society for the Promotion of Science (JSPS)
ID : 21K06788
Organisme : MEXT | JST | Core Research for Evolutional Science and Technology (CREST)
ID : JPMJCR1854
Organisme : MEXT | JST | Exploratory Research for Advanced Technology (ERATO)
ID : JPMJER1802
Organisme : EC | European Research Council (ERC)
ID : Advanced Grant #693021
Organisme : Agence Nationale de la Recherche (ANR)
ID : ANR-23-CE16-0010-03
Organisme : Fondation pour la Recherche Médicale (FRM)
ID : fellowship #FDT202012010605
Organisme : Sorbonne Université (Sorbonne University)
ID : fellowship

Déclaration de conflit d'intérêts

Competing interests statement:The authors declare no competing interest.

Auteurs

Masayuki Itoh (M)

Department of Physiology, Keio University School of Medicine, Tokyo 160-8582, Japan.

Laura Piot (L)

Institut de Biologie de l'Ecole Normale Supérieure, Ecole Normale Supérieure, Université Paris Sciences & Lettres, CNRS, INSERM, Paris F-75005, France.

Laetitia Mony (L)

Institut de Biologie de l'Ecole Normale Supérieure, Ecole Normale Supérieure, Université Paris Sciences & Lettres, CNRS, INSERM, Paris F-75005, France.

Pierre Paoletti (P)

Institut de Biologie de l'Ecole Normale Supérieure, Ecole Normale Supérieure, Université Paris Sciences & Lettres, CNRS, INSERM, Paris F-75005, France.

Michisuke Yuzaki (M)

Department of Physiology, Keio University School of Medicine, Tokyo 160-8582, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH